Self-contained Breathing Apparatus Market

Publisher Grand View Research

Published Jan 29, 2026

Length 100 Pages

SKU # GV20873306

Description

Self-contained Breathing Apparatus Market Summary

The global self-contained breathing apparatus market size was valued at USD 1,651.7 million in 2025 and is projected to reach USD 2,611.6 million by 2033, growing at a CAGR of 6.0% from 2026 to 2033. Rapid industrialization, expansion of chemical storage facilities, and increased transportation of hazardous substances have elevated the risk profile of emergency response operations.

Fire departments and industrial emergency teams are therefore prioritizing self-contained breathing apparatus systems that offer extended air supply, ergonomic design, and improved mobility. The growing emphasis on preparedness and disaster response readiness, particularly in densely populated and industrialized regions, is supporting sustained market expansion.

Technological advancements in self-contained breathing apparatus design are also contributing significantly to market growth. Manufacturers are focusing on lightweight composite cylinders, enhanced face seal materials, and integrated monitoring features that improve user comfort and operational efficiency. Innovations such as heads-up displays, real-time air status indicators, and compatibility with digital safety management systems are increasing the adoption of next-generation equipment.

Global Self-contained Breathing Apparatus Market Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the self-contained breathing apparatus market on the basis of type, end use, tank type, and region:

Type Outlook (Revenue, USD Million, 2021 - 2033)
Open-Circuit SCBA
Closed-Circuit SCBA
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Fire Services
Oil & Gas
Mining
Chemical /Petrochemical
Industrial
Law Enforcement, Military and Navy
Others
Tank Type Outlook (Revenue, USD Million, 2021 - 2033)
Type I
Type II
Type III
Type IV
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Asia Pacific
China
India
Japan
South Korea
Australia
Central & South America
Brazil
Argentina
Middle East & Africa
Saudi Arabia
South Africa
UAE

Please note The report will be delivered in 2-3 business days upon order notification.

Chapter 1 Research Methodology and Scope: 1.1 Market Segmentation & Scope; 1.1.1 Regional Scope; 1.1.2 Estimates And Forecast Timeline; 1.2 Objectives; 1.2.1 Objective - 1; 1.2.2 Objective - 2; 1.2.3 Objective - 3; 1.3 List of Secondary Sources; 1.4 List of Abbreviation
Chapter 2 Executive Summary: 2.1 Market Snapshot; 2.2 Product and End Use Outlook; 2.3 Competitive Landscape
Chapter 3 U.S. Respiratory Durable Medical Equipment Market: Product Offering Estimates & Trend Analysis: 3.1 U.S. Respiratory Durable Medical Equipment Market: Product Offering Segment Dashboard; 3.2 Product Offering Movement & Market Share Analysis, 2024 & 2033; 3.3 U.S. Respiratory Durable Medical Equipment Market Size Estimates & Forecast, by Product Offering; 3.3.1 Sleep Apnea Devices; 3.3.1.1 Sleep Apnea Devices Market, 2021 - 2033 (USD Million); 3.3.1.2 Auto-titrating CPAP; 3.3.1.3 Fixed CPAP; 3.3.1.4 BiPAP/VPAP (S/T, AVAPS); 3.3.1.5 Integrated Humidifiers; 3.3.2 Oxygen Therapy; 3.3.2.1 Oxygen Therapy Market, 2021 - 2033 (USD Million); 3.3.2.2 Stationary Oxygen Concentrators; 3.3.2.3 Portable Oxygen Concentrators (POCs); 3.3.2.4 Cylinders & regulators; 3.3.2.5 Conservers; 3.3.3 Nebulizer Therapy Equipment; 3.3.3.1 Nebulizer Therapy Equipment Market, 2021 - 2033 (USD Million); 3.3.3.2 Compressor nebulizers; 3.3.3.3 Mesh Nebulizers; 3.3.3.4 Drug-specific Nebulizers; 3.3.4 Masks, Tubing, Filters & Resupply Items (Consumables); 3.3.4.1 Masks, Tubing, Filters & Resupply Items (Consumables) Market, 2021 - 2033 (USD Million); 3.3.4.2 CPAP Masks & Cushions; 3.3.4.3 Oxygen tubing & filters; 3.3.4.4 Humidifier Chambers; 3.3.4.5 Bacterial/Viral (B/V); 3.3.4.6 Aerosol Delivery Accessories; 3.3.5 Home & Transport Ventilators; 3.3.5.1 Home & Transport Ventilatorsmarket, 2021 - 2033 (USD Million); 3.3.5.2 Adult/Pediatric Long-Term Home Ventilators; 3.3.5.3 Portable Ventilators (Transport/ALS)
Chapter 4 U.S. Respiratory Durable Medical Equipment Market: Distribution & Service Channels Estimates & Trend Analysis: 4.1 U.S. Respiratory Durable Medical Equipment Market: Distribution & Service Channels Segment Dashboard; 4.2 Distribution & Service Channels Movement & Market Share Analysis, 2024 & 2033; 4.3 U.S. Respiratory Durable Medical Equipment Market Size Estimates & Forecast, by Distribution & Service Channels; 4.3.1 National Dme Networks; 4.3.1.1 National DME Networks market, 2021 - 2033 (USD Million); 4.3.2 Regional Independents; 4.3.2.1 Regional Independents Market, 2021 - 2033 (USD Million); 4.3.3 Hospital/Idn Homecare Extensions; 4.3.3.1 Hospital/IDN Homecare Extensions Market, 2021 - 2033 (USD Million); 4.3.4 Online Dme Retailers; 4.3.4.1 Online DME Retailers Market, 2021 - 2033 (USD Million)
Chapter 5 Regional/State-Level Quantified Deliverables, by Segment, 2021 - 2033, (Revenue, USD Million): 5.1 Midwest; 5.1.1 Nebraska; 5.1.1.1 Nebraska Respiratory DME Market, 2021 - 2033 (USD Million); 5.1.1.2 Demand & Patient Population; 5.1.1.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033; 5.1.1.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices; 5.1.1.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment; 5.1.1.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators; 5.1.1.2.5 Utilization and healthcare service demand metrics, By oxygen therapy; 5.1.1.3 Supplier Density & Network Mapping; 5.1.1.4 Reimbursement & Payer Landscape (2024/2025); 5.1.1.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category; 5.1.1.5 Referral & Clinical Ecosystem (2024/2025); 5.1.1.5.1 Sleep Clinics; 5.1.1.5.2 Pulmonologists; 5.1.1.5.3 Hospitals; 5.1.1.5.4 Other providers; 5.1.1.6 Regulatory & Licensing (Most recent updates to be included); 5.1.1.7 Research Methodology; 5.1.2 IOWA; 5.1.2.1 Iowa Respiratory DME Market, 2021 - 2033 (USD Million); 5.1.2.2 Demand & Patient Population; 5.1.2.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033; 5.1.2.2.2 Utilization and healthcare service demand metrics, by sleep apnea devices; 5.1.2.2.3 Utilization and healthcare service demand metrics, by nebulizers equipment; 5.1.2.2.4 Utilization and healthcare service demand metrics, by home & transport ventilators; 5.1.2.2.5 Utilization and healthcare service demand metrics, by oxygen therapy; 5.1.2.3 Supplier Density & Network Mapping; 5.1.2.4 Reimbursement & Payer Landscape (2024/2025); 5.1.2.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category; 5.1.2.5 Referral & Clinical Ecosystem (2024/2025); 5.1.2.5.1 Sleep Clinics; 5.1.2.5.2 Pulmonologists; 5.1.2.5.3 Hospitals; 5.1.2.5.4 Other providers; 5.1.2.6 Regulatory & Licensing (Most recent updates to be included); 5.1.2.1 Research Methodology; 5.1.3 KANSAS; 5.1.3.1 Kansas Respiratory DME Market, 2021 - 2033 (USD Million); 5.1.3.2 Demand & Patient Population; 5.1.3.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033; 5.1.3.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices; 5.1.3.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment; 5.1.3.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators; 5.1.3.2.5 Utilization and healthcare service demand metrics, By oxygen therapy; 5.1.3.3 Supplier Density & Network Mapping; 5.1.3.4 Reimbursement & Payer Landscape (2024/2025); 5.1.3.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category; 5.1.3.5 Referral & Clinical Ecosystem (2024/2025); 5.1.3.5.1 Sleep Clinics; 5.1.3.5.2 Pulmonologists; 5.1.3.5.3 Hospitals; 5.1.3.5.4 Other providers; 5.1.3.6 Regulatory & Licensing (Most recent updates to be included); 5.1.3.7 Research Methodology; 5.1.4 SOUTH DAKOTA; 5.1.4.1 South Dakota Respiratory DME Market, 2021 - 2033 (USD Million); 5.1.4.2 Demand & Patient Population; 5.1.4.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033; 5.1.4.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices; 5.1.4.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment; 5.1.4.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators; 5.1.4.2.5 Utilization and healthcare service demand metrics, By oxygen therapy; 5.1.4.3 Supplier Density & Network Mapping; 5.1.4.4 Reimbursement & Payer Landscape (2024/2025); 5.1.4.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category; 5.1.4.5 Referral & Clinical Ecosystem (2024/2025); 5.1.4.5.1 Sleep Clinics; 5.1.4.5.2 Pulmonologists; 5.1.4.5.3 Hospitals; 5.1.4.5.4 Other providers; 5.1.4.6 Regulatory & Licensing (Most recent updates to be included); 5.1.4.7 Research Methodology; 5.1.5 North Dakota; 5.1.5.1 North Dakota Respiratory DME Market, 2021 - 2033 (USD Million); 5.1.5.2 Demand & Patient Population; 5.1.5.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033; 5.1.5.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices; 5.1.5.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment; 5.1.5.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators; 5.1.5.2.5 Utilization and healthcare service demand metrics, By oxygen therapy; 5.1.5.3 Supplier Density & Network Mapping; 5.1.5.4 Reimbursement & Payer Landscape (2024/2025); 5.1.5.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category; 5.1.5.5 Referral & Clinical Ecosystem (2024/2025); 5.1.5.5.1 Sleep Clinics; 5.1.5.5.2 Pulmonologists; 5.1.5.5.3 Hospitals; 5.1.5.5.4 Other providers; 5.1.5.6 Regulatory & Licensing (Most recent updates to be included); 5.1.5.7 Research Methodology; 5.1.6 Missouri; 5.1.6.1 Missouri Respiratory DME Market, 2021 - 2033 (USD Million); 5.1.6.2 Demand & Patient Population; 5.1.6.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033; 5.1.6.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices; 5.1.6.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment; 5.1.6.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators; 5.1.6.2.5 Utilization and healthcare service demand metrics, By oxygen therapy; 5.1.6.3 Supplier Density & Network Mapping; 5.1.6.4 Reimbursement & Payer Landscape (2024/2025); 5.1.6.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category; 5.1.6.5 Referral & Clinical Ecosystem (2024/2025); 5.1.6.5.1 Sleep Clinics; 5.1.6.5.2 Pulmonologists; 5.1.6.5.3 Hospitals; 5.1.6.5.4 Other providers; 5.1.6.6 Regulatory & Licensing (Most recent updates to be included); 5.1.6.7 Research Methodology; 5.1.7 Minnesota; 5.1.7.1 Minnesota Respiratory DME Market, 2021 - 2033 (USD Million); 5.1.7.2 Demand & Patient Population; 5.1.7.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033; 5.1.7.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices; 5.1.7.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment; 5.1.7.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators; 5.1.7.2.5 Utilization and healthcare service demand metrics, By oxygen therapy; 5.1.7.3 Supplier Density & Network Mapping; 5.1.7.4 Reimbursement & Payer Landscape (2024/2025); 5.1.7.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category; 5.1.7.5 Referral & Clinical Ecosystem (2024/2025); 5.1.7.5.1 Sleep Clinics; 5.1.7.5.2 Pulmonologists; 5.1.7.5.3 Hospitals; 5.1.7.5.4 Other providers; 5.1.7.6 Regulatory & Licensing (Most recent updates to be included); 5.1.7.7 Research Methodology; 5.1.8 Wisconsin; 5.1.8.1 Wisconsin Respiratory DME Market, 2021 - 2033 (USD Million); 5.1.8.2 Demand & Patient Population; 5.1.8.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033; 5.1.8.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices; 5.1.8.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment; 5.1.8.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators; 5.1.8.2.5 Utilization and healthcare service demand metrics, By oxygen therapy; 5.1.8.3 Supplier Density & Network Mapping; 5.1.8.4 Reimbursement & Payer Landscape (2024/2025); 5.1.8.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category; 5.1.8.5 Referral & Clinical Ecosystem (2024/2025); 5.1.8.5.1 Sleep Clinics; 5.1.8.5.2 Pulmonologists; 5.1.8.5.3 Hospitals; 5.1.8.5.4 Other providers (PCP, ENT, etc.); 5.1.8.6 Regulatory & Licensing (Most recent updates to be included); 5.1.8.7 Research Methodology; 5.1.9 Illinois; 5.1.9.1 Illinois Respiratory DME Market, 2021 - 2033 (USD Million); 5.1.9.2 Demand & Patient Population; 5.1.9.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033; 5.1.9.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices; 5.1.9.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment; 5.1.9.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators; 5.1.9.2.5 Utilization and healthcare service demand metrics, By oxygen therapy; 5.1.9.3 Supplier Density & Network Mapping; 5.1.9.4 Reimbursement & Payer Landscape (2024/2025); 5.1.9.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category; 5.1.9.5 Referral & Clinical Ecosystem (2024/2025); 5.1.9.5.1 Sleep Clinics; 5.1.9.5.2 Pulmonologists; 5.1.9.5.3 Hospitals; 5.1.9.5.4 Other providers (PCP, ENT, etc.); 5.1.9.6 Regulatory & Licensing (Most recent updates to be included); 5.1.9.7 Research Methodology; 5.1.10 Colorado; 5.1.10.1 Colorado Respiratory DME Market, 2021 - 2033 (USD Million); 5.1.10.2 Demand & Patient Population; 5.1.10.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033; 5.1.10.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices; 5.1.10.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment; 5.1.10.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators; 5.1.10.2.5 Utilization and healthcare service demand metrics, By oxygen therapy; 5.1.10.3 Supplier Density & Network Mapping; 5.1.10.4 Reimbursement & Payer Landscape (2024/2025); 5.1.10.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category; 5.1.10.5 Referral & Clinical Ecosystem (2024/2025); 5.1.10.5.1 Sleep Clinics; 5.1.10.5.2 Pulmonologists; 5.1.10.5.3 Hospitals; 5.1.10.5.4 Other providers (PCP, ENT, etc.); 5.1.10.6 Regulatory & Licensing (Most recent updates to be included); 5.1.10.7 Research Methodology; 5.1.11 WYOMING; 5.1.11.1 Wyoming Respiratory DME Market, 2021 - 2033 (USD Million); 5.1.11.2 Demand & Patient Population; 5.1.11.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033; 5.1.11.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices; 5.1.11.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment; 5.1.11.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators; 5.1.11.2.5 Utilization and healthcare service demand metrics, By oxygen therapy; 5.1.11.3 Supplier Density & Network Mapping; 5.1.11.4 Reimbursement & Payer Landscape (2024/2025); 5.1.11.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category; 5.1.11.5 Referral & Clinical Ecosystem (2024/2025); 5.1.11.5.1 Sleep Clinics; 5.1.11.5.2 Pulmonologists; 5.1.11.5.3 Hospitals; 5.1.11.5.4 Other providers (PCP, ENT, etc.); 5.1.11.6 Regulatory & Licensing (Most recent updates to be included); 5.1.11.7 Research Methodology; 5.1.12 OHIO; 5.1.12.1 Ohio Respiratory DME Market, 2021 - 2033 (USD Million); 5.1.12.2 Demand & Patient Population; 5.1.12.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033; 5.1.12.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices; 5.1.12.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment; 5.1.12.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators; 5.1.12.2.5 Utilization and healthcare service demand metrics, By oxygen therapy; 5.1.12.3 Supplier Density & Network Mapping; 5.1.12.4 Reimbursement & Payer Landscape (2024/2025); 5.1.12.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category; 5.1.12.5 Referral & Clinical Ecosystem (2024/2025); 5.1.12.5.1 Sleep Clinics; 5.1.12.5.2 Pulmonologists; 5.1.12.5.3 Hospitals; 5.1.12.5.4 Other providers (PCP, ENT, etc.); 5.1.12.6 Regulatory & Licensing (Most recent updates to be included); 5.1.12.7 Research Methodology; 5.1.13 INDIANA; 5.1.13.1 Indiana Respiratory DME Market, 2021 - 2033 (USD Million); 5.1.13.2 Demand & Patient Population; 5.1.13.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033; 5.1.13.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices; 5.1.13.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment; 5.1.13.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators; 5.1.13.2.5 Utilization and healthcare service demand metrics, By oxygen therapy; 5.1.13.3 Supplier Density & Network Mapping; 5.1.13.4 Reimbursement & Payer Landscape (2024/2025); 5.1.13.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category; 5.1.13.5 Referral & Clinical Ecosystem (2024/2025); 5.1.13.5.1 Sleep Clinics; 5.1.13.5.2 Pulmonologists; 5.1.13.5.3 Hospitals; 5.1.13.5.4 Other providers (PCP, ENT, etc.); 5.1.13.6 Regulatory & Licensing (Most recent updates to be included); 5.1.13.7 Research Methodology
Chapter 6 Competitive Analysis: 6.1 Participant’s Overview; 6.1.1 Tier 1 (National DME Providers); 6.1.2 Tier 2 (OEM Manufacturers); 6.1.3 Tier 3 (Regional Independents); 6.2 Financial Performance; 6.2.1 Tier 1 (National DME Providers); 6.2.1.1 Public Companies; 6.2.1.2 Private Companies; 6.2.2 Tier 2 (OEM Manufacturers); 6.2.2.1 Public Companies; 6.2.2.2 Private Companies; 6.2.3 Tier 3 (Regional Independents); 6.2.3.1 Private Companies; 6.3 Product Benchmarking; 6.3.1 Tier 1 (National DME Providers); 6.3.1.1 Sleep Apnea Devices; 6.3.1.2 Oxygen Therapy; 6.3.1.2.1 Portable Oxygen Concentrators; 6.3.1.2.2 Stationary Oxygen Concentrators; 6.3.1.3 Nebulizer Therapy Equipment; 6.3.1.4 Masks, Tubing, Filters & Resupply Items (Consumables); 6.3.1.5 Home & Transport Ventilators; 6.3.2 Tier 2 (OEM Manufacturers); 6.3.2.1 Sleep Apnea Devices; 6.3.2.2 Oxygen Therapy; 6.3.2.2.1 Portable Oxygen Concentrators; 6.3.2.2.2 Stationary Oxygen Concentrators; 6.3.2.3 Nebulizer Therapy Equipment; 6.3.2.4 Masks, Tubing, Filters & Resupply Items (Consumables); 6.3.2.5 Home & Transport Ventilators; 6.3.3 Tier 3 (Regional Independents); 6.3.3.1 Sleep Apnea Devices; 6.3.3.2 Oxygen Therapy; 6.3.3.2.1 Portable Oxygen Concentrators; 6.3.3.2.2 Stationary Oxygen Concentrators; 6.3.3.3 Nebulizer Therapy Equipment; 6.3.3.4 Masks, Tubing, Filters & Resupply Items (Consumables); 6.3.3.5 Home & Transport Ventilators; 6.4 Participant Categorization; 6.5 Company Market Position Analysis; 6.5.1 Tier 1 (National DME Providers); 6.5.2 Tier 2 (OEM Manufacturers); 6.5.1 Tier 3 (Regional Independents); 6.6 Exit Strategies of Existing Market Players and Their Impact On Market Competitors; 6.6.1 Medical Depot, Inc. Dba Drive Devilbiss Healthcare; 6.6.1.1 Medical Depot, Inc. dba Drive DeVilbiss Healthcare’s Exit Strategy Aims to Realign the Company with its Mission and Vision; 6.6.1.2 Entry of React Health following Medical Depot, Inc. dba Drive DeVilbiss Healthcare’s exit and its anticipated impact; 6.6.2 Philips Respironics; 6.6.2.1 Philips Respironics Exit Strategy Stems from Regulatory Pressure, Reputational Impact, And Portfolio Realignment; 6.6.3 Fisher & Paykel Healthcare; 6.6.3.1 Exit Strategy of Fisher & Paykel Healthcare for F&P Sleep Style CPAP in the U.S.; 6.6.4 Invacare; 6.6.4.1 Invacare's Exit Strategy Aims to Realign the Company with Its Mission and Vision.; 6.6.4.2 Entry of React Health Following Invacare's Exit and Its Anticipated Impact; 6.6.5 Resmed; 6.6.5.1 ResMed’s Exit Strategy from the Portable Oxygen Concentrator (POC) Market; 6.6.6 Medtronic; 6.6.6.1 Medtronic Exit Strategy; 6.6.7 Teleflex Incorporated; 6.6.7.1 Teleflex Incorporated Exit Strategy; 6.6.8 Breas Medical AB; 6.6.8.1 Breas Medical - Exit Strategy for Z1 & Z2 Series CPAP Devices; 6.7 Strategy Mapping; 6.7.1 Tier 1 (National DME Providers); 6.7.1.1 Mergers and Acquisitions; 6.7.1.2 Collaborations & Partnerships; 6.7.2 Tier 2 (OEM Manufacturers); 6.7.2.1 New Product Launch; 6.7.2.2 Mergers and Acquisitions; 6.7.2.3 Other Strategies; 6.7.3 Tier 3 (Regional Independents); 6.7.3.1 Mergers and Acquisitions; 6.8 List of Other Market Players

Pricing

Currency Rates

Single User Email from Publisher $5,950
Multi User License Fulfilled by Publisher $6,950
Global Site License Email from Publisher $8,950

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now